Plaque psoriasis is a common disease that causes red, scaly, raised lesions on the skin, most commonly on the elbows, knees, scalp, and back. Psoriasis affects about 2% of the population and significantly decreases health-related quality of life. It is a chronic inflammatory condition associated with systemic diseases.
For questions or additional information, please contact email@example.com
Interventions of Interest:
- Anti IL-23 agents: Guselkumab (Tremfya®, Janssen/Johnson & Johnson), tildrakizumab (Ilumya™, Sun Pharma), risankizumab (Skyrizi®, AbbVie)
- Anti TNF agent: Certolizumab pegol (Cimzia®, UCB)
View the Key Stakeholders List.
Below you will find the final documents from the assessment review process: